誉衡药业股价下跌1.57% 公司回应分红条件暂未满足

Group 1 - The stock price of Yuheng Pharmaceutical is reported at 3.75 yuan as of August 5, 2025, reflecting a decrease of 0.06 yuan or 1.57% from the previous trading day [1] - The company operates in the chemical pharmaceutical sector, focusing on drug research, production, and sales [1] - Yuheng Pharmaceutical has not met the conditions for dividend distribution due to accumulated unremedied losses being negative [1] Group 2 - The company completed a share repurchase plan in March 2025, buying back a total of 32.3072 million shares at a cost of approximately 80 million yuan [1] - On August 5, the stock experienced a rapid rebound with an increase of over 2% within five minutes, but subsequently fell back [1] - The net outflow of main funds on that day was 7.9332 million yuan, while there was a net inflow of 100 million yuan over the past five days [1]